{"id":484040,"date":"2021-04-29T07:05:24","date_gmt":"2021-04-29T11:05:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/"},"modified":"2021-04-29T07:05:24","modified_gmt":"2021-04-29T11:05:24","slug":"baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/","title":{"rendered":"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MALVERN, Pa., April  29, 2021  (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on developing and commercializing innovative products   for acute care settings, today announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021. Baudax Bio\u2019s management team will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 5, 2021 to discuss the financial results and recent operational highlights.<\/p>\n<p align=\"justify\">To access the conference call please dial (866) 220-5595 (local) or (615) 622-8062 (international) at least 10 minutes prior to the start time and refer to conference ID 5444429. A live audio webcast of the call will be available under \u201cEvents\u201d in the Investor section of the Company\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EgIZJTk1L25DUGC81fWSb9el-0vJqSQ9sLBRjQ2_hcCGm5oq519JXBjdxwTZqPAYcSru8qzGYV09r3pDvDJhiVI2xvcmrG9CpHAdXjJPS5rLrHIfmJGKjdM4N9x5WppQyZR6VdNPz4PLV9v3TTi78eEWZU5peQ_q8Bytm4VQhgo=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.baudaxbio.com\/news-and-investors\/events<\/a>. An archived webcast will be available on the Company\u2019s website approximately two hours after the event and will be available for 30 days.<\/p>\n<p>\n        <strong>About Baudax Bio<\/strong>\n      <\/p>\n<p align=\"justify\">Baudax Bio is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings. The launch of Baudax Bio\u2019s first commercial product ANJESO<sup>\u00ae<\/sup> began in mid-2020. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain, which can be administered alone or in combination with other non-NSAID analgesics. It has successfully completed three Phase III clinical trials, including two pivotal efficacy trials, a large double-blind Phase III safety trial and a Phase IIIB program evaluating ANJESO and its health economic impact in specific surgical settings. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBAs) and a proprietary chemical reversal agent specific to these NMBAs which is currently in preclinical studies. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lf8ETZfcTyht40Kqn6Z866YH3J5-SQxpfL-YkvC5SnHRjGnmJrAmcvK1YlmmsrzAAWaoGeRdlh74kdRtHJv_og==\" rel=\"nofollow noopener\" target=\"_blank\">www.baudaxbio.com<\/a>.<\/p>\n<p>\n        <strong>Cautionary Statement Regarding Forward Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements reflect Baudax Bio\u2019s expectations about its future performance and opportunities that involve substantial risks and uncertainties. When used herein, the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cmay,\u201d \u201cupcoming,\u201d \u201cplan,\u201d \u201ctarget,\u201d \u201cgoal,\u201d \u201cintend,\u201d and \u201cexpect,\u201d and similar expressions, as they relate to Baudax Bio or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information available to Baudax Bio as of the date of publication on this internet site and are subject to a number of risks, uncertainties, and other factors that could cause Baudax Bio\u2019s performance to differ materially from those expressed in, or implied by, these forward-looking statements. These forward-looking statements are subject to risks and uncertainties including, among other things, the completion of the registered direct offering and the intended use of proceeds from the registered direct offering, the ongoing economic and social consequences of the COVID-19 pandemic, including any adverse impact on the commercial launch of ANJESO\u00ae or disruption in supply chain, Baudax Bio\u2019s ability to maintain regulatory approval for ANJESO, Baudax Bio\u2019s ability to successfully commercialize ANJESO; the acceptance of ANJESO by the medical community, including physicians, patients, health care providers and hospital formularies; Baudax Bio\u2019s ability and that of Baudax Bio\u2019s third party manufacturers to successfully scale-up our commercial manufacturing process for ANJESO, Baudax Bio\u2019s ability to produce commercial supply in quantities and quality sufficient to satisfy market demand for ANJESO, Baudax Bio\u2019s ability to raise future financing for continued product development, payment of milestones and ANJESO commercialization, Baudax Bio\u2019s ability to pay its debt and satisfy conditions necessary to access future tranches of debt, Baudax Bio\u2019s ability to comply with the financial and other covenants under its credit facility, Baudax Bio\u2019s ability to manage costs and execute on our operational and budget plans, the accuracy of Baudax Bio\u2019s estimates of the potential market for ANJESO, Baudax Bio\u2019s ability to achieve its financial goals; and Baudax Bio\u2019s ability to obtain, maintain and successfully enforce adequate patent and other intellectual property protection. These forward-looking statements should be considered together with the risks and uncertainties that may affect Baudax Bio\u2019s business and future results included in Baudax Bio\u2019s filings with the Securities and Exchange Commission at www.sec.gov. These forward-looking statements are based on information currently available to Baudax Bio, and Baudax Bio assumes no obligation to update any forward-looking statements except as required by applicable law.<\/p>\n<p>\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<p>Investor Relations Contact:<br \/>Argot Partners<br \/>Sam Martin \/ Claudia Styslinger<br \/>(212) 600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4SGeRLdBy947JUVxGcL69z2WdZiSuKBbH5_EJwkIH5BvK1BRdY4EoCCCkdo8UPVtdlO9w2a8yrU4y3y5kLp_sVMLgXlbnmk8u973bscFtXQeH4R6Morv5booZiYU1nhk\" rel=\"nofollow noopener\" target=\"_blank\">baudaxbio@argotpartners.com<\/a><\/p>\n<p>Media Contact:<br \/>Argot Partners<br \/>David Rosen<br \/>(212) 600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=735h8bnDaB8DEH_-guqRjA-9DHjvcKd0vmX7a82_DV3cXXp6b8JrO9BisChYrEM7PktXnt17cWFuLe3RM8HhUWiwqngK1VbxAgR8sLnswlPIRMsrfJDfE94rPGRACa_N\" rel=\"nofollow noopener\" target=\"_blank\">david.rosen@argotpartners.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0b0b96bd-b499-4235-ac5b-55fb332fd02e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021. Baudax Bio\u2019s management team will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 5, 2021 to discuss the financial results and recent operational highlights. To access the conference call please dial (866) 220-5595 (local) or (615) 622-8062 (international) at least 10 minutes prior to the start time and refer to conference ID 5444429. A live audio webcast of the call will be available under \u201cEvents\u201d in the Investor section of the Company\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484040","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021. Baudax Bio\u2019s management team will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 5, 2021 to discuss the financial results and recent operational highlights. To access the conference call please dial (866) 220-5595 (local) or (615) 622-8062 (international) at least 10 minutes prior to the start time and refer to conference ID 5444429. A live audio webcast of the call will be available under \u201cEvents\u201d in the Investor section of the Company\u2019s &hellip; Continue reading &quot;Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T11:05:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021\",\"datePublished\":\"2021-04-29T11:05:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/\"},\"wordCount\":760,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/\",\"name\":\"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=\",\"datePublished\":\"2021-04-29T11:05:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/","og_locale":"en_US","og_type":"article","og_title":"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 - Market Newsdesk","og_description":"MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021. Baudax Bio\u2019s management team will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 5, 2021 to discuss the financial results and recent operational highlights. To access the conference call please dial (866) 220-5595 (local) or (615) 622-8062 (international) at least 10 minutes prior to the start time and refer to conference ID 5444429. A live audio webcast of the call will be available under \u201cEvents\u201d in the Investor section of the Company\u2019s &hellip; Continue reading \"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T11:05:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021","datePublished":"2021-04-29T11:05:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/"},"wordCount":760,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/","name":"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=","datePublished":"2021-04-29T11:05:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjA1MyM0MTQ1MjI5IzIxOTM0NDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-report-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-5-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484040"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484040\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}